Bayer’s pharmaceutical business may finally be entering a long-awaited growth cycle, but CEO Bill Anderson still can’t quite ...
Bayer (XTRA:BAYN) and MustGrow Biologics reported confirmed field trial results for TerraMG biocontrol technology across ...
Bayer has seen its share price surge in recent months, which puts fresh attention on whether the current valuation lines up ...
Bayer AG is rated a Hold after a robust Q3, with Pharma outperforming expectations and driving operating leverage. Read more ...
Press Trust of India on MSN
Bayer to invest Rs 200 crore in Karnataka; MoU signed
Bengaluru, Nov 6 (PTI) German multinational Bayer Science and Innovation will invest Rs 200 crore to establish a state-of-the-art manufacturing facility near Bengaluru ...
Bayer Crop Science at the 9th CIIE [Photo provided to chinadaily.com.cn] Eight China debuts and six CIIE debuts: advancing ...
The next hard checkpoint is scheduled for November 3, when Bayer releases its Q3 2026 interim report at 07:30 CET. An ...
Bayer says a news report claiming the company is trying to spin off its Crop Science division “is based purely on speculation.” The Platow Brief, a German business publication, said Friday it was ...
Bayer AG makes polymers, as those of us in the industry know quite well. But now that company has run into “junk science,” which has plagued the plastics industry for several decades. When Bayer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results